Should You Buy Clarivate PLC (CLVT) Today? Analysis, Price Targets, and 2026 Outlook.
No data
Options Data
No data
Growth
Profitability
Efficiency
Wall Street analysts forecast CLVT stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for CLVT is 3.9 USD with a low forecast of 3 USD and a high forecast of 5 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
5 Analyst Rating
Wall Street analysts forecast CLVT stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for CLVT is 3.9 USD with a low forecast of 3 USD and a high forecast of 5 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
0 Buy
3 Hold
2 Sell
Moderate Sell
Current: 2.740
Low
3
Averages
3.9
High
5
Current: 2.740
Low
3
Averages
3.9
High
5
Goldman Sachs
Buy
to
Neutral
downgrade
AI Analysis
2026-01-08
Reason
Goldman Sachs
Price Target
AI Analysis
2026-01-08
downgrade
Buy
to
Neutral
Reason
Goldman Sachs downgraded Clarivate to Neutral from Buy with a price target of $3.60, down from $4.20. The firm says the company's "Value Creation Plan" will require an extended timeframe to produce meaningful improvements in organic revenue growth. Clarivate's revenue growth will be slow by increasing competition from AI-native entrants across its segments and its limited ability to drive pricing increases beyond low-single-digits, the analyst tells investors in a research note.
Morgan Stanley
Equal Weight -> Underweight
downgrade
$5 -> $3
2025-12-17
Reason
Morgan Stanley
Price Target
$5 -> $3
2025-12-17
downgrade
Equal Weight -> Underweight
Reason
Morgan Stanley downgraded Clarivate to Underweight from Equal Weight with a price target of $3, down from $5. The firm sees continued share underperformance for Clarivate as its turnaround "continues to struggle." The company faces tight budgets and competition, and its strategic review will not yield much value, the analyst tells investors in a research note.
Unlock Full Analyst Thesis， Get the complete breakdown of rating reason for CLVT
